Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study.

Westenberger A,Skrahina V,Usnich T,Beetz C,Vollstedt EJ,Laabs BH,Paul JJ,Curado F,Skobalj S,Gaber H,Olmedillas M,Bogdanovic X,Ameziane N,Schell N,Aasly JO,Afshari M,Agarwal P,Aldred J,Alonso F,Anderson R,Araújo R,Arkadir D,Avenali M,Balal M,Benizri S,Bette S,Bhatia P,Bonello M,Braga P,Brauneis S,Cardoso F,Cavallieri F,Classen J,Cohen L,Coletta D,Crosiers D,Cullufi P,Dashtipour K,Demirkiran M,Aguiar PD,De Rosa A,Djaldetti R,Dogu O,Ghilardi MGD,Eggers C,Elibol B,Ellenbogen A,Ertan S,Fabiani G,Falkenburger BH,Farrow S,Fay T,Ferencz GJ,Fonoff ET,Fragoso YD,Genç G,Gorospe A,Grandas F,Gruber D,Gudesblatt M,Gurevich T,Hagenah J,Hanagasi HA,Hassin S,Hauser RA,Hernández J,Herting B,Hinson VK,Hogg E,Hu MT,Hummelgen E,Hussey K,Infante J,Isaacson SH,Jauma S,Koleva N,Kuhlenbäumer G,Kühn A,Litvan I,López L,Luxmore M,Manandhar S,Marcaud V,Markopoulou K,Marras C,McKenzie M,Matarazzo M,Merello M,Mollenhauer B,Morgan JC,Mullin S,Musacchio T,Myers B,Negrotti A,Nieves A,Nitsan Z,Oskooilar N,Öztop Ö,Pal G,Pavese N,Percesepe A,Piccoli T,de Souza CP,Prell T,Pulera M,Raw J,Reetz K,Reiner J,Rosenberg D,Ruiz M,Ruiz J,Sammler E,Santos BL,Saunders R,Schlesinger I,Schofield CM,Schumacher AF,Scott B,Sesar ,Shafer SJ,Sheridan R,Silverdale M,Sophia R,Spitz M,Stathis P,Stocchi F,Tagliati M,Tai YF,Terwecoren A,Thonke S,Tönges L,Toschi G,Tumas V,Urban PP,Vacca L,Vandenberghe W,Valente EM,Valzania F,Vela L,Weill C,Weise D,Wojcieszek J,Wolz M,Yahalom G,Yalcin G,Zittel S,Zlotnik Y,Kandaswamy KK,Balck A,Hanssen H,Borsche M,Lange LM,Csoti I,Lohmann K,Kasten M,Brüggemann N,Rolfs A,Klein C,Bauer P. Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study. Brain. 2024. 147. (8):p. 2652-2667. IF:14,500. (1).